US Patent 8420376 Use of
Patent 8420376 was granted and assigned to Probi AB on April, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+239 characters)
Article
Patent abstract
The present technology relates to the use of at least one strain of probiotic bacteria selected from Lactobacillus for the manufacture of a pharmaceutical composition for the treatment and/or prevention of a virus infection.
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08420376 Use of US Patent 8420376 Use of
Infobox
Patent Number
0842037600
Patent Number
842037600
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084203760
Date of Patent
April 16, 2013
0Patent Application Number
119924880
Date Filed
October 6, 2006
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084203760
Date of Patent
April 16, 2013
0Patent Application Number
119924880
Date Filed
October 6, 2006
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08420376 Use of
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08420376
Date of patent
April 16, 2013
Patent application number
11992488
Date Filed
October 6, 2006
Patent primary examiner
Find more entities like US Patent 8420376 Use of
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.